Company Filing History:
Years Active: 2013-2014
Title: Eric Thoenes: Innovator in GLP-1 Peptide Technologies
Introduction
Eric Thoenes is a notable inventor based in Budingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of GLP-1 fusion peptides. With a total of 3 patents to his name, Thoenes has focused on innovations that have the potential to impact the treatment of various diseases.
Latest Patents
One of Thoenes' latest patents is centered around GLP-1 fusion peptides. This invention provides fusion peptides that exhibit GLP-1 activity and enhanced stability in vivo, particularly resistance to dipeptidyl peptidase IV. The fusion peptide comprises a GLP-1 sequence as component (I) and a peptide sequence of at least 9 amino acids as component (II). This innovation may be utilized in preparing medicaments for treating conditions such as type 1 and type 2 diabetes, as well as neurodegenerative disorders.
Another significant patent involves spherical microcapsules that contain GLP-1 peptides. These microcapsules feature a surface coating made of cross-linked polymers and a core that includes cells capable of expressing and secreting GLP-1 peptides. The production methods and applications of these microcapsules are directed towards treating type 2 diabetes, weight disorders, and neurodegenerative diseases.
Career Highlights
Throughout his career, Eric Thoenes has worked with reputable companies such as Biocompatibles UK Limited and Cellmed AG. His work in these organizations has allowed him to further develop his expertise in biotechnology and peptide research.
Collaborations
Some of Thoenes' notable coworkers include Peter Geigle and Christine Wallrapp. Their collaborative efforts have contributed to advancements in the field of GLP-1 peptide technologies.
Conclusion
Eric Thoenes is a distinguished inventor whose work in GLP-1 fusion peptides and microcapsules holds promise for the treatment of various medical conditions. His contributions to biotechnology continue to pave the way for innovative solutions in healthcare.